CORREVIO PHARMA Balance Sheet - Quarterly (NASDAQ:CORV)

Add to My Stocks
$4.39 $0.05 (1.13%) CORV stock closing price Sep 19, 2018 (Closing)
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Cash23.95M15.75M24.18M29.12M31.26M22.14M29.3M34.17M15.51M14.2M
Marketable Securities----------
Receivables6.55M7.44M6.38M6.26M5.39M5.49M6.15M5.04M7.44M8.41M
Inventory5.55M6.12M6.42M6.29M6.36M5.72M4.61M4.51M4.43M4.43M
Raw Materials1.95M2.21M2.21M2.06M-2.2M2.29M2.42M2.46M2.54M
Work In Progress----------
Finished Goods2.81M3.27M3.32M3.52M-2.7M1.75M1.44M1.38M1.08M
Notes Receivable----------
Other Current Assets-1.15M-1.52M1.21M1.48M1.76M2.04M2.25M2.25M
Total Current Assets
36.81M30.48M37.95M43.2M44.24M34.84M41.83M45.78M29.64M29.31M
Property Plant & Equipment1.09M1.1M-1.69M1.69M1.68M1.68M1.71M1.71M1.71M
Accumulated Depreciation---1.23M1.21M1.17M1.13M1.1M1.06M1.01M
Net Property Plant & Equipment
----------
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Intangibles28.86M27.66M28.12M28.76M24.03M24.05M24.67M26.18M26.97M14.08M
Deposits & Other Assets----------
Total Assets
66.56M59.07M66.81M72.88M69.21M59.86M67.05M72.56M57.26M44.08M
Notes Payable----------
Accounts Payable8.67M7.46M7.7M7.62M7.33M7.25M8.02M6.83M18.1M8.3M
Current Portion Long-Term Debt---------3.89M
Current Portion Capital Leases----------
Accrued Expenses----------
Income Taxes Payable----------
Other Current Liabilities----1.86M2.4M2.99M3.02M3.06M2.95M
Total Current Liabilities
8.97M7.68M7.9M7.83M9.2M9.65M11.01M9.85M21.16M15.15M
Mortgages----------
Deferred Taxes/Income2.69M2.88M2.5M2.51M2.47M2.36M2.38M2.57M2.55M2.59M
Convertible Debt----------
Long-Term Debt39.95M39.21M40M39.01M28.44M19.43M19.39M19.34M19.31M4.76M
Non-Current Capital Leases----------
Other Long-Term Liabilities--------1.44M2.09M
Total Liabilities
51.8M49.98M50.62M49.58M40.35M31.69M33.03M32.52M44.47M24.6M
Minority Interest----------
Preferred Stock----------
Common Stock Net354.13M354.11M353.48M352.71M352.39M345.17M344.92M344.74M312.98M312.82M
Capital Surplus39.93M39.33M38.44M38.07M37.5M35.96M35.81M35.57M34.94M34.93M
Retained Earnings-396.2M-401.62M-392.86M-384.52M-377.89M-369.38M-363.05M-357.46M-352.18M-344.66M
Treasury Stock----------
Other Liabilities16.9M17.27M17.12M17.03M16.86M16.42M16.33M17.18M17.04M16.38M
Shareholders Equity14.76M9.09M16.19M23.3M28.86M28.17M34.02M40.04M12.78M19.47M
Total Liabilities & Shareholders Equity66.56M59.07M66.81M72.88M69.21M59.86M67.05M72.56M57.26M44.08M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

CORREVIO PHARMA Balance Sheet - Key Ratios

Current ratio
4.1
Debt to equity ratio
2.71
Asset turnover ratio
0.39
Receivables turnover
4.02
Price to book ratio
8.3